Eusa Pharma

Showing 8 posts of 8 posts found.

shutterstock_38078521

EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients

July 2, 2020
Research and Development COVID-19, Eusa Pharma, siltuximab

Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …

eusa

EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients

April 2, 2020
Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab

EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …

shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020
Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …

EUSA Pharma bolsters senior leadership team with two appointments

May 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eusa Pharma, appointment

Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two …

chemo-web

EUSA Pharma acquires global rights to oncology support drug

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Eusa Pharma, acroral, acroral tab, global rights, oncology

EUSA Pharma has announced the acquisition of global rights to oncology support care product, Arcoral Tab, from Arcoral Pharma.

goran_ando

EUSA Pharma appoints chief executive and director

April 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley

Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …

Stephen Stamp joins board at Eusa Pharma

September 7, 2010
Sales and Marketing Eusa Pharma, appointment, sales and marketing

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …

Eusa Pharma appoints Iain McGill

March 10, 2010
Sales and Marketing Eusa Pharma, appointment, sales and marketing

Iain McGill has joined specialty company Eusa Pharma as international and European president. He moves to Eusa from Wyeth Pharmaceutical, …

The Gateway to Local Adoption Series

Latest content